成人神经母细胞瘤无原发灶时骨骼系统异常18F-FDG与18F-MFBG摄取
一例30岁女性因反复发热和全血细胞减少就诊,18F-FDG PET/CT显示弥漫性骨骼受累,骨髓活检确诊神经母细胞瘤,接受靶向化疗后临床试验中18F-MFBG PET/CT显示多发骨转移,两种显像均未发现原发肿瘤部位。
要点
- 成人神经母细胞瘤可表现为广泛骨受累而无 detectable 原发灶。
- 18F-FDG PET/CT可显示弥漫性骨骼转移。
- 18F-MFBG PET/CT也可显示多发骨转移,但均未定位原发灶。
核心结论
- 成人转移性神经母细胞瘤可表现为广泛骨受累而无可检测的原发肿瘤,即使使用18F-FDG和18F-MFBG两种功能显像亦然。
研究设计与样本
- 一例30岁女性病例报告,因反复发热和全血细胞减少接受评估。
主要发现
- 18F-FDG PET/CT显示弥漫性骨骼受累,符合播散性转移性疾病。
- 骨髓活检组织病理学分析确诊神经母细胞瘤。
- 靶向化疗后临床试验中18F-MFBG PET/CT显示多发骨转移。
- 两种显像均未识别原发肿瘤部位。
临床怎么用
- 对成人不明原因骨病变伴全血细胞减少,需考虑神经母细胞瘤可能,即使功能显像未发现原发灶。
局限性
- 单个病例报告,结论不能推广至所有成人神经母细胞瘤患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 30-year-old woman was evaluated for recurrent fever and pancytopenia. 18F-FDG PET/CT revealed diffuse skeletal involvement, consistent with disseminated metastatic disease. Histopathologic analysis of a bone marrow biopsy confirmed the diagnosis of neuroblastoma. The patient subsequently received neuroblastoma-targeted chemotherapy. Following treatment, she participated in a clinical trial and underwent an 18F-MFBG PET/CT examination, which demonstrated multiple skeletal metastases. Notably, neither imaging modality identified a primary tumor site. This case illustrates that metastatic neuroblastoma in adults may present with extensive osseous involvement in the absence of a detectable primary tumor, even after comprehensive functional imaging with both 18F-FDG and 18F-MFBG.
引用
- Wang X, Zhang B, Lv C, et al. Abnormal 18F-FDG and 18F-MFBG Uptake in the Skeletal System of an Adult Patient With Neuroblastoma in the Absence of a Detectable Primary Tumor. Clin Nucl Med. 2026. PMID: 41941230. doi:10.1097/RLU.0000000000006314
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。